6550--HbA1c CPT IDIQ VISN 22

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

262-NETWORK CONTRACT OFFICE 22 (36C262)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C26226Q0140

NAICS

325413 - In-Vitro Diagnostic Substance Manufacturing

Classification Code

6550

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents1
The Department of Veterans Affairs, through its Network Contract Office 22 (NCO 22), has issued an award notice for an Indefinite Delivery/Indefinite Quantity (IDIQ) contract related to HbA1c CPT, under procurement identifier 36C26226Q0140. This procurement falls under the North American Industry Classification System (NAICS) code 325413, which pertains to In-Vitro Diagnostic Substance Manufacturing, indicating a focus on the supply of diagnostic substances used in laboratory testing, specifically for the measurement of Hemoglobin A1c (HbA1c) levels. The primary objective of this contract is to ensure a reliable and consistent supply of HbA1c testing products across the facilities within VISN 22, which is a regional network within the Veterans Health Administration. The intended outcome is to support the ongoing clinical needs of veterans by providing high-quality diagnostic materials essential for the monitoring and management of diabetes and related conditions. The contract structure as an IDIQ allows for flexibility in ordering quantities over the contract period, ensuring that the varying demands of the network can be met efficiently. Key requirements for this procurement include the provision of in-vitro diagnostic substances that meet stringent quality and regulatory standards suitable for use in a clinical laboratory environment. Contractors are expected to deliver products that are compatible with existing laboratory equipment and workflows within the VISN 22 network. The deliverables will primarily consist of HbA1c testing reagents and associated consumables, with the expectation of timely and reliable delivery to multiple VA medical facilities as needed. The contracting entity for this opportunity is the 262-Network Contract Office 22, a federal office within the Department of Veterans Affairs. The primary point of contact for this procurement is Clift Domen, who can be reached via email at [email protected] or by phone at 562-766-2241. The notice remains active as of the posting date, March 18, 2026, and further details, including any attachments, can be accessed through the official SAM.gov opportunity listing at https://sam.gov/opp/aec378b237be4eb0a159962989651dfb/view. This procurement is classified under Product Service Code 6550, which covers in-vitro diagnostic substances, aligning with the NAICS code and the nature of the required products. While the notice does not specify any set-aside requirements or special considerations, contractors should be prepared to demonstrate their capability to supply high-quality diagnostic substances in accordance with federal procurement standards and the specific needs of the VA healthcare system. Overall, this opportunity is well-suited for manufacturers and suppliers with experience in in-vitro diagnostic substances, particularly those with a proven track record of supporting large healthcare networks and meeting the rigorous standards of federal healthcare procurement.